文献速递分子诊断临床免疫临床微生物

HHV-6A/B基因分型在免疫抑制成人中的诊断价值

Diagnostic value of HHV-6A/B genotyping in immunocompromised adults.
PubMed 文献 · J Clin Microbiol · 2026-06-29

本研究回顾性分析2020至2025年间119例可检出HHV-6 DNA的免疫抑制成人,采用实时PCR检测病毒种别,并通过毛囊中eHHV-6 DNA确认染色体整合。HHV-6B约占96%感染且与器官受累(主要为胃肠道疾病)显著相关,HHV-6A则与病毒血症和染色体整合一致相关,种级分型有助于避免不必要的抗病毒治疗。

要点

  • HHV-6B占感染约96%,与器官受累(尤胃肠道)显著相关,不依赖血浆病毒载量。
  • HHV-6A较少见于组织,但与病毒血症和染色体整合一致相关,不依赖病毒载量。
  • 同一患者血浆、活检、脑脊液、肺泡灌洗液和毛囊样本的基因型完全一致。

核心结论

  • HHV-6A检测与染色体整合相关,HHV-6B是临床相关疾病和侵袭性组织感染的主要种别。
  • 将种级基因分型和eHHV-6靶向检测纳入诊断流程可改善病毒检出解读并避免不必要的抗病毒治疗。

研究设计与样本

  • 回顾性研究纳入2020至2025年间119例可检出HHV-6 DNA的免疫抑制成人。
  • 采用实时PCR在多种样本类型中检测病毒种别,并通过毛囊中eHHV-6 DNA的定量实时PCR确认疑似染色体整合。

主要发现

  • HHV-6B约占感染的96%,与器官受累(主要为胃肠道疾病)显著相关,不依赖血浆病毒载量。
  • HHV-6A在组织中检出较少,与病毒血症和染色体整合一致相关,不依赖病毒载量。
  • 同一患者血浆、活检、脑脊液、肺泡灌洗液和毛囊样本的基因型完全一致。

临床怎么用

  • 在免疫抑制患者中开展HHV-6种级PCR检测,以区分HHV-6A与HHV-6B。
  • 对疑似染色体整合者检测毛囊eHHV-6 DNA,避免将整合病毒误判为活动性感染。
  • 结合种级分型结果解读病毒DNA检出,减少不必要的抗病毒治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Human herpesvirus 6 (HHV-6) comprises two genetically and biologically distinct species, HHV-6A and HHV-6B, yet species-level differentiation is rarely performed in clinical practice. We conducted a retrospective study of 119 immunocompromised adults with detectable HHV-6 DNA between 2020 and 2025 to characterize species distribution, compare epidemiological, clinical, and virological features, and evaluate the diagnostic relevance of genotyping. Viral species were detected by real-time polymerase chain reaction (PCR) across multiple sample types, and suspected chromosomal integration was confirmed through detection of endogenous HHV-6 (eHHV-6) DNA in hair follicles by quantitative real-time PCR. HHV-6B accounted for ~96% of infections and was significantly associated with organ involvement, predominantly gastrointestinal disease, irrespective of plasma viral load. In contrast, HHV-6A was less frequently detected in tissues and was consistently associated with viremia and chromosomal integration, independent of viral load. Genotypic concordance across plasma, biopsy, cerebrospinal fluid, bronchoalveolar lavage, and hair follicle samples from the same patient was complete. Incorporating species-level genotyping and targeted testing for chromosomal integration (eHHV-6) into diagnostic workflows may improve interpretation of viral detection and help prevent unnecessary antiviral therapy.IMPORTANCESpecies-specific identification of human herpesvirus 6 (HHV-6A/B) has critical diagnostic implications in immunocompromised patients, although it is rarely performed in diagnostic laboratories. Our study showed that HHV-6A detection is associated with chromosomal integration, whereas HHV-6B is the main species linked to clinically relevant disease and invasive tissue infection. This study emphasizes that implementing species-specific PCR and testing for eHHV-6 in clinical microbiology laboratories may help interpret viral DNA detection, prevent misclassification of integrated virus as active infection, and avoid unnecessary antiviral therapy.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Lorente V, Charry P, Guardia A, et al. Diagnostic value of HHV-6A/B genotyping in immunocompromised adults. J Clin Microbiol. 2026. PMID: 42370689. doi:10.1128/jcm.01898-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。